Paid Clinical Trials in Lansing, MI
As of June 2026, 140 paid clinical trials are recruiting in Lansing, Michigan. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Lansing offers studies at sites including University of Michigan Health - Sparrow Lansing for conditions such as Breast Cancer, Stage IV Lung Cancer AJCC v8, Stage IVB Prostate Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Lansing
Filter results
0 clinical trials
·Clear filters·↓ Download CSVAbout research studies in Lansing
Lansing has approximately 140 recruiting research studies across a wide range of therapeutic areas. Michigan hosts University of Michigan Health, Henry Ford Health, and Corewell Health, running trials across oncology, neurology, and cardiology with a strong focus on precision medicine.
Top Research Study Locations in Lansing
Researchers run research studies in Lansing, MI at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| University of Michigan Health - Sparrow Lansing | Stage IV Lung Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Recurrent Lung Non-Small Cell Carcinoma | 66 |
| Karmanos Cancer Institute at McLaren Greater Lansing | Anatomic Stage II Breast Cancer AJCC v8, Breast Cancer, Clinical Stage III Esophageal Adenocarcinoma AJCC v8 | 22 |
| Sparrow Clinical Research Institute | Aortic Stenosis, Community-acquired Pneumonia, Coronary Artery Disease | 7 |
| McLaren Greater Lansing | Acute Myocardial Infarction (AMI), Cardiovascular Risk, Infection Mixed | 4 |
| Alkermes Investigational Site | Narcolepsy Type 1, Narcolepsy Type 2, Idiopathic Hypersomnia | 3 |
| Sparrow Hospital | Anatomic Stage IV Breast Cancer AJCC v8, Cardiotoxicity, Castration Levels of Testosterone | 3 |
| Great Lakes Center of Rheumatology | Active Rheumatoid Arthritis, Systemic Lupus Erythematosus | 2 |
| Michigan State University | Acute Ischemic Stroke, Cancer Prevention, HPV Vaccination | 2 |
| Sparrow Cancer Center | Breast Cancer, Locally Advanced or Metastatic Solid Tumor Harboring an NTRK Gene Fusion | 2 |
| Advanced Rheumatology PC | Lansing, MI | Psoriatic Arthritis | 1 |
| Alkermes Investigator Site | Idiopathic Hypersomnia | 1 |
| Anthos Investigative Site 1021 | Atrial Fibrillation (AF) | 1 |
| Barbara Ann Karmanos Cancer Institute | Metastatic Castration-resistant Prostate Cancer | 1 |
| Barbara Ann Karmanos Cancer Institute - McLaren Greater Lansing /ID# 259891 | Multiple Myeloma | 1 |
| Clinical Study Site | Non-Small Cell Lung Cancer | 1 |
| Clinical Trial Site | Generalized Myasthenia Gravis | 1 |
| E.W Sparrow Hospital | Stone Ureter, Stone, Kidney | 1 |
| GSK Investigational Site | Systemic Lupus Erythematosus | 1 |
| Genesis Surgery Center | Lumbar Spinal Stenosis | 1 |
| Henry Ford + Michigan State University Health Center | Alcohol Use Disorder, Alcohol-related Liver Disease | 1 |
| Herbert-Herman Cancer Center, Sparrow Hospital | Angiosarcoma, Breast Cancer, Breast Neoplasms | 1 |
| Home-based telemedicine | Chronic Granulomatous Disease (CGD) | 1 |
| Ingham Nephrology & Hypertension, P.C. | Kidney Disease | 1 |
| June DO, PC | Systemic Lupus Erythematosus | 1 |
| June DO, PC Private Practice - Dr. Justus Fiechtner | Psoriatic Arthritis | 1 |
Active & Upcoming Studies in Lansing (2026)
Recruiting trials in Lansing grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (86 active studies)
- A Study of the TheraBionic P1 Device in Breast Cancer · Barbara Ann Karmanos Cancer Institute
- Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays · Alliance for Clinical Trials in Oncology
Cardiovascular (10 active studies)
- A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity · Phase 3 · Novo Nordisk A/S
- Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention · Phase 4 · Duke University
Neurology & pain (3 active studies)
- Evaluation of the Efficacy of STRATAFIX for Neurosurgical Cranial and Spine Procedures · Phase 4 · University of Michigan
- Proximal Internal Carotid Artery Acute Stroke Secondary to Tandem or Local Occlusion Thrombectomy Trial · Phase 3 · Mercy Health Ohio
Diabetes & metabolic (2 active studies)
Vaccines (1 active study)
Mental health & behavior (1 active study)
- E-Mindfulness Approaches for Living After Breast Cancer · Phase 3 · NRG Oncology
Common conditions studied in Lansing
- Breast Cancer (7 active studies). Breast cancer trials evaluate new hormone therapies, targeted drugs, and immunotherapy combinations aimed at improving survival and reducing recurrence.
- Stage IV Lung Cancer AJCC v8 (7 active studies). Lung cancer research focuses on targeted therapies for specific mutations such as EGFR, ALK, and KRAS, alongside immunotherapy regimens.
- Stage IVB Prostate Cancer AJCC v8 (5 active studies). Prostate cancer studies test next-generation hormone therapies, PARP inhibitors, and radioligand treatments for both localized and advanced disease.
- Anatomic Stage II Breast Cancer AJCC v8 (4 active studies). Breast cancer trials evaluate new hormone therapies, targeted drugs, and immunotherapy combinations aimed at improving survival and reducing recurrence.
- Anatomic Stage IV Breast Cancer AJCC v8 (4 active studies). Breast cancer trials evaluate new hormone therapies, targeted drugs, and immunotherapy combinations aimed at improving survival and reducing recurrence.
- Recurrent Lung Non-Small Cell Carcinoma (4 active studies). ENT (otolaryngology) trials evaluate new treatments for hearing loss, swallowing disorders, and head and neck cancers — covering pharmacologic, surgical, and rehabilitative approaches.
Leading research sponsors in Lansing
- National Cancer Institute (NCI)
- SWOG Cancer Research Network
- NRG Oncology
- Alliance for Clinical Trials in Oncology
- ECOG-ACRIN Cancer Research Group
Local regulations and guidelines
Clinical trials in Michigan are governed by U.S. Food and Drug Administration (FDA) regulations, Office for Human Research Protections (OHRP) standards, and federal HIPAA privacy rules. Every study is reviewed by an Institutional Review Board (IRB) to protect participant safety and ensure informed consent. Michigan research additionally follows state public health department oversight and any applicable state privacy statutes.
Compensation & what to expect
- How payment typically works
- Compensation is most often provided through reloadable electronic study cards or direct deposit, paid out per completed visit rather than as a lump sum. Amounts vary by the time required, the number of visits, and the study's complexity — overnight stays and inpatient pharmacology studies generally pay more than short outpatient surveys. The exact amount is disclosed in writing during informed consent before any visit.
- Healthy volunteers
- Healthy participants aged 18 and older can earn compensation by joining vaccine, pharmacology, and biomarker studies in Lansing. These trials check how a new drug or vaccine behaves in healthy bodies before later-phase testing. Many sites maintain a healthy-volunteer registry so you hear about new opportunities first.
- What's included beyond payment
- Most trials cover study-related medical care at no cost — physical exams, lab work, imaging, the investigational treatment itself, and follow-up visits with the research team. Insurance is not required to participate. Free check-ups and access to specialists are common reasons participants return for additional studies.
- Travel and time
- Many sponsors reimburse travel, parking, mileage, and lost wages for visit days. Long-running studies and trials that require frequent visits often raise stipends accordingly. Ask the study coordinator for the visit schedule and reimbursement policy before you commit.
- Asking about compensation
- Compensation is set per protocol and per site, so figures are not published in trial registries. The fastest way to confirm payment for a specific study is to contact the recruiting site listed on the study record. Coordinators are accustomed to this question and will quote the per-visit and total amounts up front.
How to find a clinical trial in Lansing
Hipa.ai aggregates every recruiting study in Lansing from ClinicalTrials.gov and refreshes the list daily. Use the filters above to narrow by condition, facility, age, phase, or healthy-volunteer eligibility, then click any study title to view full details — eligibility criteria, intervention, location, and sponsor contact information. To enroll, reach out to the central study contact listed on the study detail page; the research coordinator will walk you through the screening process.
Frequently asked questions
How many paid clinical trials are currently recruiting in Lansing?
There are approximately 140 recruiting clinical trials in Lansing, Michigan listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Lansing pay participants?
Most recruiting trials in Lansing compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Lansing?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Lansing?
The most common conditions under active study in Lansing include Breast Cancer (7), Stage IV Lung Cancer AJCC v8 (7), Stage IVB Prostate Cancer AJCC v8 (5), Anatomic Stage II Breast Cancer AJCC v8 (4), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Lansing?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Lansing on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Lansing?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Lansing?
Recruiting research sites in Lansing include University of Michigan Health - Sparrow Lansing, Karmanos Cancer Institute at McLaren Greater Lansing, Sparrow Clinical Research Institute, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Lansing right now?
The largest active categories in Lansing are Cancer & tumors (86), Cardiovascular (10), Neurology & pain (3). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.